REPRODUCTIVE FACTORS AND THE RISK OF HEPATOCELLULAR-CARCINOMA IN WOMEN

被引:24
作者
LAVECCHIA, C
NEGRI, E
FRANCESCHI, S
DAVANZO, B
机构
[1] UNIV LAUSANNE,INST SOCIAL & PREVENT MED,CH-1005 LAUSANNE,SWITZERLAND
[2] AVIANO CANC CTR,I-33081 AVIANO,ITALY
关键词
D O I
10.1002/ijc.2910520304
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The relationship between reproductive factors and the risk of primary liver cancer was analyzed using data of a case-control study conducted in Northern Italy between 1984 and 1991 on 79 women with histologically or serologically confirmed hepatocellular carcinoma and 344 controls in hospital for a wide spectrum of acute, non-neoplastic diseases. The multivariate relative risk (RR) for parous vs. nulliparous women was 2.6 (95% confidence interval (Cl) 1.2 to 5.8), and the risk increased with parity from 2.1 for 1, to 2.6 for 2, to 3.2 for 3, to 3.5 for 4 or more births (chi1(2) trend = 6.49, p = 0.01). The relative risks were above unity, though not significantly, in women reporting spontaneous (RR = 1.3) and induced (RR = 1.6) abortions, and there was a significant trend in risk with total number of abortions. An apparent inverse trend in risk with age and first birth was accounted for by parity. No relationship emerged with age at menarche, at menopause or other menstrual factors. The association between parity and hepatocellular carcinoma was, if anything, more marked at older ages, since the RR was 1.6 (95% Cl 0.5 to 4.6) below age 60, and 4.8 (95% Cl 1.3 to 18.1) at age 60 or over. This observation has relevant public-health implications, since in developed countries primary liver cancer is extremely rare among young women, but not at older ages. The association between parity and hepatocellular carcinoma is similar to that described for combined oral contraceptives, again confirming that the impact of contraceptives on the risk of several neoplasms is similar to that of pregnancy.
引用
收藏
页码:351 / 354
页数:4
相关论文
共 25 条
[1]  
BAKER RJ, 1978, GLIM SYSTEM
[2]  
BAUM JK, 1973, LANCET, V2, P926
[3]  
Breslow NE, 1980, IARC SCI PUBLICATION, V1
[4]  
Cislaghi C, 1986, DATI INDICATORI MAPP
[5]   CANCER OF THE LIVER AND THE USE OF ORAL-CONTRACEPTIVES [J].
FORMAN, D ;
VINCENT, TJ ;
DOLL, R .
BRITISH MEDICAL JOURNAL, 1986, 292 (6532) :1357-1361
[6]   HEPATOCELLULAR-CARCINOMA AND ORAL-CONTRACEPTIVES [J].
HENDERSON, BE ;
PRESTONMARTIN, S ;
EDMONDSON, HA ;
PETERS, RL ;
PIKE, MC .
BRITISH JOURNAL OF CANCER, 1983, 48 (03) :437-440
[7]  
HIGASHI S, 1980, GANN, V71, P576
[8]   ORAL-CONTRACEPTIVES AND PRIMARY LIVER-CANCER AMONG YOUNG-WOMEN [J].
HSING, AW ;
HOOVER, RN ;
MCLAUGHLIN, JK ;
COCHIEN, HT ;
WACHOLDER, S ;
BLOT, WJ ;
FRAUMENI, JF .
CANCER CAUSES & CONTROL, 1992, 3 (01) :43-48
[9]   RISK-FACTORS FOR HEPATOCELLULAR-CARCINOMA IN NORTHERN ITALY [J].
LAVECCHIA, C ;
NEGRI, E ;
DECARLI, A ;
DAVANZO, B ;
FRANCESCHI, S .
INTERNATIONAL JOURNAL OF CANCER, 1988, 42 (06) :872-876
[10]   ORAL-CONTRACEPTIVES AND PRIMARY LIVER-CANCER [J].
LAVECCHIA, C ;
NEGRI, E ;
PARAZZINI, F .
BRITISH JOURNAL OF CANCER, 1989, 59 (03) :460-461